<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/9FAEB115-B448-4CE5-A56F-A6A270B4C57A"><gtr:id>9FAEB115-B448-4CE5-A56F-A6A270B4C57A</gtr:id><gtr:name>International Federation of Gynecology and Obstetrics (FIGO)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>Centre of Population Health Sciences</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/9FAEB115-B448-4CE5-A56F-A6A270B4C57A"><gtr:id>9FAEB115-B448-4CE5-A56F-A6A270B4C57A</gtr:id><gtr:name>International Federation of Gynecology and Obstetrics (FIGO)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/7A87CA46-2BDA-497E-B3E3-5A77105370F6"><gtr:id>7A87CA46-2BDA-497E-B3E3-5A77105370F6</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:otherNames>Gilbert</gtr:otherNames><gtr:surname>Hillier</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/21EA1447-F026-4766-BCD9-34C3B90E210E"><gtr:id>21EA1447-F026-4766-BCD9-34C3B90E210E</gtr:id><gtr:firstName>Hilary</gtr:firstName><gtr:otherNames>Octavia</gtr:otherNames><gtr:surname>Critchley</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/E4868624-9BFF-4719-B82F-BA9D336CCBEB"><gtr:id>E4868624-9BFF-4719-B82F-BA9D336CCBEB</gtr:id><gtr:firstName>James</gtr:firstName><gtr:otherNames>Ian</gtr:otherNames><gtr:surname>Mason</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0500047"><gtr:id>D1C09132-912E-4B80-8D5B-4940A63D2AFD</gtr:id><gtr:title>Local Cortisol (CORT) Regulation in Ovarian and Uterine Disorders</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0500047</gtr:grantReference><gtr:abstractText>A major call on healthcare budgets and clinical facilities relates to medical conditions associated with two cyclical reproductive processes; menstruation (periods) and ovulation (monthly release of an egg). Menstrual complaints carry an annual treatment cost of over #65million. Surgical management for menstrual complaints continues to rise and it is younger women who mostly contribute to this increase. There is an urgent need to identify medical alternatives to surgery. One in seventy women will develop significant disease of the ovary and ovarian cancer is the leading cause of death from gynaecological cancer. Risk factors include childlessness and increased number of ovulations. By contrast, the oral contraceptive pill significantly reduces the risk. Menstruation and ovulation have much in common as both are inflammatory events with repeat episodes of tissue growth, injury and repair of the damaged tissue ( ovarian surface or womb-lining, known as endometrium). We wish to focus in depth on how the key anti-inflammatory molecule, cortisol (CORT) is made available to cells of the ovarian surface or endometrium to accomplish cell repair at the very site of ovulation or menstrual injury. Our proposed research programme will combine expertise in basic science and clinical medicine. With ovarian and uterine tissue samples from women we will use modern cellular and molecular biological techniques to undertake a detailed study of the molecules and mechanisms, and specifically regulation and dysregulation of cortisol production in the ovary and uterus. We will thus be better able to understand the mending processes involved in local tissue repair post-menses and post-ovulation, and how these may be dysregulated in gynaecological disease - ovarian cancer and abnormal bleeding. An enhanced understanding of the control mechanisms responsible for normal resolution of inflammation in the reproductive tract will hold the key to the development of improved methods not only of diagnosis, but importantly, also for novel treatment approaches to these debilitating conditions. Most importantly these studies will contribute to our understanding of processes involved in development of ovarian cancer and abnormal uterine bleeding.

To keep our local community appraised, the University of Edinburgh Centre for Reproductive Biology (CRB) has a Public Lecture Series on Reproductive Health which will begin in 2005 with four information evenings during the year. Short informative lectures will be followed by discussion on the research topics being addressed in the CRB that directly impact Reproductive Health.</gtr:abstractText><gtr:technicalSummary>The ovaries and uterus are sources of debilitating or life-threatening gynaecological conditions such as ovarian cancer and disorders of menstrual bleeding. This is because ovulation and menstruation are serial injury-repair processes centred upon an acute inflammatory episode, which if inadequately resolved predisposes to chronic tissue injury. We find that during ovulation and menstruation, human ovarian surface epithelium (HOSE, source of 90% epithelial ovarian cancers) and uterine endometrium (HUTE, source of menstrual dysfunction) normally mount an anti-inflammatory response involving local alterations in the expression and activities of 11betahydroxysteroid dehydrogenase (11betaHSD) enzymes that regulate formation of cortisol (CORT) from bio-inert cortisone, thereby gating access of anti-inflammatory CORT to nuclear glucocorticoid receptors (GR) in post-ovulatory and post-menstrual tissue lesions. Our central hypothesis is that 11betaHSD1, which predominantly activates cortisone to CORT, is up-regulated by pro-inflammatory cytokines in HOSE and HUTE to localise and contain post-ovulatory and post-menstrual injury-repair processes. Further, dysregulation of 11 beta hydroxysteroid dehydrogenase enzymes (11betaHSDs)is an hitherto unrecognised key factor in disease in the reproductive tract. We therefore propose three questions seeking to determine (1) how 11betaHSD enzyme activity is regulated in the female reproductive tract; (2) the relevance of cortisol (CORT) activation to inflammation associated ovarian disease, including ovarian cancer; and (3) whether aberrant CORT activation is a determinant of abnormal uterine bleeding. We will elucidate mechanisms of CORT activation in healthy HOSE and HUTE and comprehend CORT dysregulation in diseased tissues, emphasising ovarian cancer. In uterus, given the particularly high healthcare burden posed by abnormalities of menstrual bleeding, we focus on the angiostatic properties of CORT in HUTE. The outcomes are expected to have broad relevance to the management of other major disease states with an inflammatory basis - including cardiovascular, respiratory and cancer.</gtr:technicalSummary><gtr:fund><gtr:end>2008-09-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>639021</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Reproductive Biology</gtr:department><gtr:description>Studies on human fallopian tube and ectopic pregnancy</gtr:description><gtr:id>D31C6561-D394-4224-B688-04AB31397F10</gtr:id><gtr:impact>Mentorship of trainee clinical academic who subsequently has been awarded an MRC Clinician Scientist Fellowship 2009-13 Successful joint grant awarded from Wellbeing of Women 2008-10 Joint publications: 19864448; 20047737; 20651036; 20864676; 20978183; 21047920; PMID:22685224</gtr:impact><gtr:partnerContribution>Intellectual input and exchange of ideas. Development of collaborative research programme</gtr:partnerContribution><gtr:piContribution>Provision of intellectual input and exchange of ideas - expertise in uterine biology Opportunity to study female reproductive disorders due to ready access to clinical primary tissue resource</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Inflammation Research</gtr:department><gtr:description>Studies on human female reproductive tract tissues (endometrium, ovarian surface epithelium, fallopian tube, peritoneum)</gtr:description><gtr:id>05D6446D-11A6-447F-8A77-665CFADC68C0</gtr:id><gtr:impact>Joint successful grant application to MRC [2009-2012. MRC Project Grant. &amp;pound;700870 &amp;quot;Postovulatory ovarian repair: a role for LOX in scar-free adult healing]

Through Research collaboration with Bayer Pharma - sharing of endometrial RNA resource</gtr:impact><gtr:partnerContribution>Collaborative discussions have generated opportunity for joint research grant applications and shared supervision of PhD students Opportunity to share reagents and technical laboratory expertise</gtr:partnerContribution><gtr:piContribution>Provision of intellectual input and exchange of ideas - technical (molecular &amp;amp; cellular study expertise) Opportunity to study female reproductive disorders due to access to clinical primary tissue resource</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Inflammation Research</gtr:department><gtr:description>Studies on uterine immune cells</gtr:description><gtr:id>EA3C5DD9-7931-45E2-BBFC-ABFE74C37288</gtr:id><gtr:impact>Novel preliminary data necessary for preparation of collaborative grant applications. Co-supervision of current PhD student.
Publications: 19196802 and PMID:23108100</gtr:impact><gtr:partnerContribution>Exchange of ideas and expertise (molecular and cellular)</gtr:partnerContribution><gtr:piContribution>Opportunity to study isolated immune cells from primary human uterine tissues</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>International Federation of Gynecology and Obstetrics (FIGO)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>FIGO Menstrual Disorders Working Group</gtr:description><gtr:id>52DF6428-5E78-4080-8BFD-60F457EDDBEA</gtr:id><gtr:impact>Publications:
PMID 22386064
PMID 22068978
PMID 22065329
PMID 22065324</gtr:impact><gtr:partnerContribution>Established a FIGO endorsed classification for abnormal uterine bleeding. Within this classification is a sub-classification &amp;quot;Endometrium&amp;quot; molecular and cellular causes of abnormal uterine bleeding and studies arising from this MRC funding have helped inform endometrial biology in this area.

Also within this classification is a sub-classification for fibroids</gtr:partnerContribution><gtr:piContribution>Current member FIGO menstrual disorders committee (previously Co-Chair with colleagues from USA and Australia).</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Human Reproductive Sciences Unit</gtr:department><gtr:description>Studies on human endometrium</gtr:description><gtr:id>A224DE69-88FF-4C92-B502-4E7D7F8ADC9B</gtr:id><gtr:impact>Successful joint research grant application to the Wellcome Trust Joint publications: 19955102; 19208787;19196802;18775884; 18032694; 19955102; 20668045; 20885978 
 IP - patent submitted but not supported beyond first year</gtr:impact><gtr:partnerContribution>Collaboration has generated opportunity for successful joint research grant application; shared supervision of PhD students;</gtr:partnerContribution><gtr:piContribution>Provision of intellectual input and exchange of ideas - expertise in endometrial biology Opportunity to study female reproductive disorders due to ready access to clinical primary tissue resource</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>media article on menstruation (Why Menstruation Remains a Medical Mystery: https://uk.news.yahoo.com/why-menstruation-remains-medical-mystery-215459035.html)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8B98EEAA-3246-4AFE-8C1D-F9C4723E5800</gtr:id><gtr:impact>media interest in article (peer-reviewed - review type article highlighting research contributions) on menstruation: Live Science.com
https://uk.news.yahoo.com/why-menstruation-remains-medical-mystery-215459035.html</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>https://uk.news.yahoo.com/why-menstruation-remains-medical-mystery-215459035.html</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> Invited speaker and participant Scientific Workshop (Bayer Schering Pharma Ag) 2008</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8894DF6D-407F-40D8-9144-248DE5176ADA</gtr:id><gtr:impact>Scientific Meeting, Scientific Workshop on &amp;quot;IUS and Uterine Bleeding&amp;quot;, Bayer Schering Pharma AG, Berlin 9-10 June 2008 Invited speaker: Human endometrial function: role of progesterone withdrawal in endometrial (breakthrough) bleeding.

Raised profile to industry of importance of menstrual bleeding problems and impact of menstrual disorders of health and quality of life to many women</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio interview BBC Scotland's Newsdrive</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>7AB3AB94-7CEE-48D7-8C4C-84A47F9181F4</gtr:id><gtr:impact>Interviewed by BBC Scotland Newsdrive programme on subject of studies on helping women with heavy menstrual bleeding.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited speaker and participant Scientific Meeting (Preglem 2012)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>79C04A56-C77C-4C51-83F7-6588F3D0B5F2</gtr:id><gtr:impact>Scientific Meeting on &amp;quot;SPRMs and a new treatment for uterine fibroids&amp;quot;, Preglem , Leeds 22 May 2012. Invited speaker: Progesterone receptor modulators (PRMs), effects on the endometrium.

Raised profile to indudstry of importance of menstrual bleeding problems and impact of menstrual disorders of health and quality of life to many women.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public Talk (2014)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>7BA60728-6358-4561-A3E6-67E037C731E0</gtr:id><gtr:impact>MRC Centre for Reproductive Health Public Talk, Edinburgh 19 February 2014. Invited speaker: Blood Vessel Route to Solving Problem Periods. Audience mainly school pupils and the public.

Audience mainly school pupils and the public and event received positive feedback. Discussion with school pupils and general public about impact of research on important women's health clinical complaints. Interest expressed in work experience at Edinburgh Royal Infirmary by one member of audience who subsequently obtained one week work experience placement June 2014.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public lecture (2008)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>DAA890B0-2B74-42A2-A110-350A06807FD3</gtr:id><gtr:impact>Centre for Reproductive Biology Public lecture series, Edinburgh Invited speakers: Periods: a bleeding pain! Will it ever be possible to make every week of the month bearable? Audience mainly school students and the public

Audience mainly school students and the public and event received positive feedback Discussion with school pupils and general public about impact of research on important women's health clinical complaints</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public Lecture (2012)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>F8FBA734-F36C-4951-963E-3196ACD29FB9</gtr:id><gtr:impact>MRC Centre for Reproductive Health Public Talk, Edinburgh 25 January 2012. Invited speaker: Heavy menstrual bleeding: a period drama. Audience mainly school pupils and the public.

Audience mainly school pupils and the public and event received positive feedback. Discussion with school pupils and general public about impact of research on important women's health clinical complaints.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited  speaker MRC Showcase Programme (Edinburgh)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E0A18F14-F3B9-4CCC-A873-1F611CE75F18</gtr:id><gtr:impact>MRC Showcase Programme, Physiological Systems and Clinical Sciences Board, 11 - 12 September 2007. Edinburgh. Inflammation Invited speaker: Injury and repair in the female reproductive tract. Audience was mixture of scientists from academia and industry

FIGO international meeting Rome; topic abnormal uterine bleeding; Audience was mixture of scientists and clinicians from academia, industry and in clinical practice 


Co-organiser &amp;amp; speaker at industry (Bayer Schering Pharma) forum on abnormal uterine bleeding, Berlin Germany -- 20-30 international experts (academia &amp;amp; industry)

Speaker at Nordic Ob/GYN society (Norway) annual meeting (approx 100 participants)

Discussions with scientists working in industry</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2007,2010,2011,2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1642538</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Developmental Clinical Studies Grant</gtr:description><gtr:end>2016-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/J003611/1</gtr:fundingRef><gtr:id>B83B6FEB-9C63-4B40-AA90-9DED804B259F</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>15000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Initiating Knowledge Transfer Fund (IKTF), University of Edinburgh, Project Grant</gtr:description><gtr:end>2010-03-02</gtr:end><gtr:fundingOrg>University of Edinburgh</gtr:fundingOrg><gtr:fundingRef>4M-1100</gtr:fundingRef><gtr:id>C827ECB9-D517-4AB5-AB9F-EA56FF8E5A6B</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>128455</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research Project Grant</gtr:description><gtr:end>2010-08-02</gtr:end><gtr:fundingOrg>Wellbeing of Women</gtr:fundingOrg><gtr:fundingRef>RG993</gtr:fundingRef><gtr:id>476ACAF1-E098-4F45-AE07-F65F87587FE9</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1086000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Centre application (G1002033)</gtr:description><gtr:end>2016-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G1002033</gtr:fundingRef><gtr:id>AF158E8D-8515-4484-9277-7FB22B245CA5</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>726874</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Project Grant 0900550</gtr:description><gtr:end>2013-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>FBDA7BA8-9B4A-4150-B55A-EAC2290D78AC</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>341368</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research Project Grant (Wellcome Trust 083908/Z/07/Z)</gtr:description><gtr:end>2011-12-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:fundingRef>083908/Z/07/Z</gtr:fundingRef><gtr:id>E339975F-1C0B-4126-B76C-EF2737BF5054</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-05-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Contributed to FIGO endorsed classification of Abnormal Uterine Bleeding (AUB)</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>99DA0AC4-3181-47B3-8D22-44EF1954941A</gtr:id><gtr:impact>Aim is to streamline classification of menstrual bleeding disorders
MRC funded Research has contributed to the molecular &amp;amp; cellular understanding of menstrual bleeding disorders - a component within this classification.

PI on MRC funded work is co-chair of this initiative

Publications relevant are: PMID:22386064;PMID:22065326;PMID:22065324; PMID:21496802;PMID:21345435</gtr:impact><gtr:type>Influenced training of practitioners or researchers</gtr:type><gtr:url>http://europepmc.org/abstract/MED/22386064</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Industry advisory committee (Bayer Schering Pharma AG)</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>F690C916-50D1-47BA-9C46-2510CAD53B2F</gtr:id><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>Exploration of first-in-woman use of a short oral course of low-dose dexamethasone to rescue local endometrial glucocorticoid deficiency in women with heavy menstrual bleeding (HMB)</gtr:description><gtr:id>7C4D9854-DC8D-40C5-8445-2EF386A21479</gtr:id><gtr:impact>Study in progress</gtr:impact><gtr:stage>Early clinical assessment</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>DexFEM</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:yearDevCompleted>2013</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Human female reproductive tract tissue resource -- archival tissue resource (endometrium) = well-characterised/ phenotyped</gtr:description><gtr:id>E9943875-6F5F-43DB-AC8A-B08734D04F3C</gtr:id><gtr:impact>valuable human female reproductive tract tissue resource -- archival tissue resource (endometrium) = well-characterised/ phenotyped</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Human female reproductive tract tissue resource</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Archive and prospective tissue resource with &amp;amp; tissue bank approval;</gtr:description><gtr:id>E646FDF7-F3C3-48C5-AC3C-B8C57554766F</gtr:id><gtr:impact>Multiple collaborations: local, some international and with industry

Tissue bank approval (since 2011) for this resource</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Human Female Reproductive Tract Tissue Resource</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Female reproductive tract tissue archive (human endometrium and ovarian surface/ peritoneal surface epithelium) complemented with a computerised detailed dataset of consent records and patient characteristics for study participants since 2001.</gtr:description><gtr:id>8049B9A8-BC12-4C73-B18A-99ACC8F471D0</gtr:id><gtr:impact>Invaluable resource to identify well-characterised cases for future re-use of stored tissue (with patient consent). Credible centralised source data for on-going, current and archived human female reproductive tract tissues.

We now have a &amp;quot;tissue bank approval&amp;quot; since 2011 for this resource</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Human female reproductive tract tissue resource</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/78EA0C49-0954-4E53-945A-C6691351EB28"><gtr:id>78EA0C49-0954-4E53-945A-C6691351EB28</gtr:id><gtr:title>Proliferation of uterine natural killer cells is induced by human chorionic gonadotropin and mediated via the mannose receptor.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/34192f29560b0b65713c54929c16a254"><gtr:id>34192f29560b0b65713c54929c16a254</gtr:id><gtr:otherNames>Kane N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D96984A0-330D-4A3E-BA7B-1F66F6B066C8"><gtr:id>D96984A0-330D-4A3E-BA7B-1F66F6B066C8</gtr:id><gtr:title>Anti-inflammatory steroid signalling in the human peritoneum.</gtr:title><gtr:parentPublicationTitle>The Journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/56f5fb360e1022e4aa76d8cd3cbee1cf"><gtr:id>56f5fb360e1022e4aa76d8cd3cbee1cf</gtr:id><gtr:otherNames>Fegan KS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-0795</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1E7715B8-0E5A-4FC6-985F-A4F4C2CA36FF"><gtr:id>1E7715B8-0E5A-4FC6-985F-A4F4C2CA36FF</gtr:id><gtr:title>Differential expression and regulation of nuclear oligomerization domain proteins NOD1 and NOD2 in human endometrium: a potential role in innate immune protection and menstruation.</gtr:title><gtr:parentPublicationTitle>Molecular human reproduction</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0642d635cfac3d4704dc07a1afe39d9f"><gtr:id>0642d635cfac3d4704dc07a1afe39d9f</gtr:id><gtr:otherNames>King AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1360-9947</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DC11B570-30D0-43FF-952F-32887053A56E"><gtr:id>DC11B570-30D0-43FF-952F-32887053A56E</gtr:id><gtr:title>A Role for the orphan nuclear receptor estrogen-related receptor alpha in endometrial stromal cell decidualization and expression of genes implicated in energy metabolism.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/55d5e1f3fcd5fd186e3900055a1ce6cf"><gtr:id>55d5e1f3fcd5fd186e3900055a1ce6cf</gtr:id><gtr:otherNames>Bombail V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/40DD0F66-DF0F-44DB-9A50-094E1D11E88B"><gtr:id>40DD0F66-DF0F-44DB-9A50-094E1D11E88B</gtr:id><gtr:title>TGF?1 attenuates expression of prolactin and IGFBP-1 in decidualized endometrial stromal cells by both SMAD-dependent and SMAD-independent pathways.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/272d0d63dabd429db6c30970fcf5a89a"><gtr:id>272d0d63dabd429db6c30970fcf5a89a</gtr:id><gtr:otherNames>Kane NM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/12AF29D2-0D51-498C-A7D0-F0A43FB2E6D3"><gtr:id>12AF29D2-0D51-498C-A7D0-F0A43FB2E6D3</gtr:id><gtr:title>Local estrogen metabolism in epithelial ovarian cancer suggests novel targets for therapy.</gtr:title><gtr:parentPublicationTitle>The Journal of steroid biochemistry and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6297e30d8b716ffb224209fa405d7e9f"><gtr:id>6297e30d8b716ffb224209fa405d7e9f</gtr:id><gtr:otherNames>Ren X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0960-0760</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E4E7E67C-724E-4C46-B281-4BE2A771D656"><gtr:id>E4E7E67C-724E-4C46-B281-4BE2A771D656</gtr:id><gtr:title>11Beta-hydroxysteroid dehydrogenases in human endometrium.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0fc2c74ee7a9b592ef8668efd12b0551"><gtr:id>0fc2c74ee7a9b592ef8668efd12b0551</gtr:id><gtr:otherNames>McDonald SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0303-7207</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4B3C0CC9-BC43-4333-B43D-3511ADBF933F"><gtr:id>4B3C0CC9-BC43-4333-B43D-3511ADBF933F</gtr:id><gtr:title>Molecular and cellular causes of abnormal uterine bleeding of endometrial origin.</gtr:title><gtr:parentPublicationTitle>Seminars in reproductive medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4ac0ac01fefa232a40f71da161f84a24"><gtr:id>4ac0ac01fefa232a40f71da161f84a24</gtr:id><gtr:otherNames>Critchley HO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1526-4564</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/69277059-53E8-49B1-80E6-CDA9A8CED0AB"><gtr:id>69277059-53E8-49B1-80E6-CDA9A8CED0AB</gtr:id><gtr:title>Attenuated sex steroid receptor expression in fallopian tube of women with ectopic pregnancy.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/683eaf5521022c276588d0cfaba101ab"><gtr:id>683eaf5521022c276588d0cfaba101ab</gtr:id><gtr:otherNames>Horne AW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F8FD40AE-3906-4484-BB08-29E69817762A"><gtr:id>F8FD40AE-3906-4484-BB08-29E69817762A</gtr:id><gtr:title>Menstrual physiology: implications for endometrial pathology and beyond.</gtr:title><gtr:parentPublicationTitle>Human reproduction update</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/14661cfcf1a005e8090117ba86348d2c"><gtr:id>14661cfcf1a005e8090117ba86348d2c</gtr:id><gtr:otherNames>Maybin JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1355-4786</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A24622B5-5483-4ADE-829B-78AC2F51B841"><gtr:id>A24622B5-5483-4ADE-829B-78AC2F51B841</gtr:id><gtr:title>Repair and regeneration of the human endometrium</gtr:title><gtr:parentPublicationTitle>Expert Review of Obstetrics &amp; Gynecology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e33fd2aa96b95b32af7f8ec22871ad04"><gtr:id>e33fd2aa96b95b32af7f8ec22871ad04</gtr:id><gtr:otherNames>Maybin J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/572F430E-0919-418D-950A-110D080A1705"><gtr:id>572F430E-0919-418D-950A-110D080A1705</gtr:id><gtr:title>Prostacyclin receptor up-regulates the expression of angiogenic genes in human endometrium via cross talk with epidermal growth factor Receptor and the extracellular signaling receptor kinase 1/2 pathway.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/895614482e5f96058ca46f613fe126d6"><gtr:id>895614482e5f96058ca46f613fe126d6</gtr:id><gtr:otherNames>Smith OP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/981FFFE3-EBCE-47F1-B64B-C4D3687ACD40"><gtr:id>981FFFE3-EBCE-47F1-B64B-C4D3687ACD40</gtr:id><gtr:title>Thrombospondin-1 inhibits angiogenesis and promotes follicular atresia in a novel in vitro angiogenesis assay.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3149cf63a01b68a4d98df3a7e301ba12"><gtr:id>3149cf63a01b68a4d98df3a7e301ba12</gtr:id><gtr:otherNames>Garside SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/92567137-5CBA-41BE-A5A0-96F10B5FFB75"><gtr:id>92567137-5CBA-41BE-A5A0-96F10B5FFB75</gtr:id><gtr:title>An additive interaction between the NFkappaB and estrogen receptor signalling pathways in human endometrial epithelial cells.</gtr:title><gtr:parentPublicationTitle>Human reproduction (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0642d635cfac3d4704dc07a1afe39d9f"><gtr:id>0642d635cfac3d4704dc07a1afe39d9f</gtr:id><gtr:otherNames>King AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0268-1161</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/799F3558-2A13-4314-A63F-61C7D243DD49"><gtr:id>799F3558-2A13-4314-A63F-61C7D243DD49</gtr:id><gtr:title>Cyclooxygenase enzyme expression and E series prostaglandin receptor signalling are enhanced in heavy menstruation.</gtr:title><gtr:parentPublicationTitle>Human reproduction (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/895614482e5f96058ca46f613fe126d6"><gtr:id>895614482e5f96058ca46f613fe126d6</gtr:id><gtr:otherNames>Smith OP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0268-1161</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2F01C6B6-F90C-4173-A921-9E9F856ABAFA"><gtr:id>2F01C6B6-F90C-4173-A921-9E9F856ABAFA</gtr:id><gtr:title>Mid-luteal endometrial intracrinology following controlled ovarian hyperstimulation involving use of a gonadotrophin releasing hormone antagonist.</gtr:title><gtr:parentPublicationTitle>Human reproduction (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1e396a0e280933ea96adcf1f03fcd466"><gtr:id>1e396a0e280933ea96adcf1f03fcd466</gtr:id><gtr:otherNames>Vani S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0268-1161</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E08E285D-7A57-456C-B55D-31833BB44838"><gtr:id>E08E285D-7A57-456C-B55D-31833BB44838</gtr:id><gtr:title>Glucocorticoid receptor-mediated regulation of MMP9 gene expression in human ovarian surface epithelial cells.</gtr:title><gtr:parentPublicationTitle>Fertility and sterility</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5ccf21a9a183560a3e2e59191483bff7"><gtr:id>5ccf21a9a183560a3e2e59191483bff7</gtr:id><gtr:otherNames>Rae MT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0015-0282</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BBB90912-E8F4-495B-98AD-9FAAD2002ED0"><gtr:id>BBB90912-E8F4-495B-98AD-9FAAD2002ED0</gtr:id><gtr:title>Transforming growth factor-beta1 attenuates expression of both the progesterone receptor and Dickkopf in differentiated human endometrial stromal cells.</gtr:title><gtr:parentPublicationTitle>Molecular endocrinology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/34192f29560b0b65713c54929c16a254"><gtr:id>34192f29560b0b65713c54929c16a254</gtr:id><gtr:otherNames>Kane N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0888-8809</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1C77E733-596D-4CF2-8FC3-13CED9C6E775"><gtr:id>1C77E733-596D-4CF2-8FC3-13CED9C6E775</gtr:id><gtr:title>Oestrogen and progesterone regulation of inflammatory processes in the human endometrium.</gtr:title><gtr:parentPublicationTitle>The Journal of steroid biochemistry and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0642d635cfac3d4704dc07a1afe39d9f"><gtr:id>0642d635cfac3d4704dc07a1afe39d9f</gtr:id><gtr:otherNames>King AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0960-0760</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/283DE92D-FB9F-4CDA-8769-CA3D5D317770"><gtr:id>283DE92D-FB9F-4CDA-8769-CA3D5D317770</gtr:id><gtr:title>3beta-Hydroxysteroid dehydrogenases and pre-receptor steroid metabolism in the human ovarian surface epithelium.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5407218b4867b821dad18860ad5a2f02"><gtr:id>5407218b4867b821dad18860ad5a2f02</gtr:id><gtr:otherNames>Papacleovoulou G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0303-7207</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/90BCAB86-AAE3-42F5-943C-8EBCE8A9DC11"><gtr:id>90BCAB86-AAE3-42F5-943C-8EBCE8A9DC11</gtr:id><gtr:title>IL1a and IL4 signalling in human ovarian surface epithelial cells.</gtr:title><gtr:parentPublicationTitle>The Journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5407218b4867b821dad18860ad5a2f02"><gtr:id>5407218b4867b821dad18860ad5a2f02</gtr:id><gtr:otherNames>Papacleovoulou G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-0795</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1AA67DF2-E4CD-4166-962B-BBC778C80BC6"><gtr:id>1AA67DF2-E4CD-4166-962B-BBC778C80BC6</gtr:id><gtr:title>Thyroid hormone signaling in human ovarian surface epithelial cells.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5ccf21a9a183560a3e2e59191483bff7"><gtr:id>5ccf21a9a183560a3e2e59191483bff7</gtr:id><gtr:otherNames>Rae MT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F84D4483-6E0F-4B6C-BC5F-D98AA93422E8"><gtr:id>F84D4483-6E0F-4B6C-BC5F-D98AA93422E8</gtr:id><gtr:title>Estrogen receptor related beta is expressed in human endometrium throughout the normal menstrual cycle.</gtr:title><gtr:parentPublicationTitle>Human reproduction (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/55d5e1f3fcd5fd186e3900055a1ce6cf"><gtr:id>55d5e1f3fcd5fd186e3900055a1ce6cf</gtr:id><gtr:otherNames>Bombail V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0268-1161</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4127A025-5CF7-439E-9A6F-A3CE3BA480C2"><gtr:id>4127A025-5CF7-439E-9A6F-A3CE3BA480C2</gtr:id><gtr:title>Hormone receptor dynamics in a receptive human endometrium.</gtr:title><gtr:parentPublicationTitle>Reproductive sciences (Thousand Oaks, Calif.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4ac0ac01fefa232a40f71da161f84a24"><gtr:id>4ac0ac01fefa232a40f71da161f84a24</gtr:id><gtr:otherNames>Critchley HO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1933-7191</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/92F55838-1F27-4E93-AEA4-23CBD7044EF6"><gtr:id>92F55838-1F27-4E93-AEA4-23CBD7044EF6</gtr:id><gtr:title>Regulation of 3beta-hydroxysteroid dehydrogenase type 1 and type 2 gene expression and function in the human ovarian surface epithelium by cytokines.</gtr:title><gtr:parentPublicationTitle>Molecular human reproduction</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5407218b4867b821dad18860ad5a2f02"><gtr:id>5407218b4867b821dad18860ad5a2f02</gtr:id><gtr:otherNames>Papacleovoulou G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1360-9947</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A5C091BB-D835-4A3B-86A7-26C32D2BF7A5"><gtr:id>A5C091BB-D835-4A3B-86A7-26C32D2BF7A5</gtr:id><gtr:title>Cortisol inactivation by 11beta-hydroxysteroid dehydrogenase-2 may enhance endometrial angiogenesis via reduced thrombospondin-1 in heavy menstruation.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2ba941afcef5ea52bbc7627fad5c912a"><gtr:id>2ba941afcef5ea52bbc7627fad5c912a</gtr:id><gtr:otherNames>Rae M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0500047</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>FA7AA693-7EDD-4A7E-8CA3-6B5658FBF717</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Reproductive Health and Childbirth</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>